New Horizons Pharma, 49 Amethyst Way, Ste 1, San Francisco, CA 94131, US

Olema Pharmaceuticals, Inc., based in San Francisco, CA, is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers. With a single-minded focus, Olema Oncology leverages its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to develop more convenient and effective therapies, aiming to transform the standard of care for women living with cancer. Olema Oncology's mission is to improve the lives of women living with cancer by developing therapies that offer the potential to enhance outcomes. Through their dedication and expertise, they aim to design therapies that are both convenient and effective, with the goal of advancing into clinical development by the end of 2024. With a commitment to transforming the standard of care, Olema Oncology is at the forefront of developing targeted therapies for women's cancers.Generated from the website